Cite
Mokhtari RB, Sambi M, Qorri B, et al. The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. Cancers (Basel). 2021;13(14)doi: 10.3390/cancers13143596.
Mokhtari, R. B., Sambi, M., Qorri, B., Baluch, N., Ashayeri, N., Kumar, S., Cheng, H. M., Yeger, H., Das, B., & Szewczuk, M. R. (2021). The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. Cancers, 13(14), . https://doi.org/10.3390/cancers13143596
Mokhtari, Reza Bayat, et al. "The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy." Cancers vol. 13,14 (2021). doi: https://doi.org/10.3390/cancers13143596
Mokhtari RB, Sambi M, Qorri B, Baluch N, Ashayeri N, Kumar S, Cheng HM, Yeger H, Das B, Szewczuk MR. The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. Cancers (Basel). 2021 Jul 18;13(14). doi: 10.3390/cancers13143596. PMID: 34298809; PMCID: PMC8305317.
Copy
Download .nbib
